Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis

I read with interest the article by yilmaz et al. regarding the value of aspartate aminotransferases (ast)–to–platelet ratio index (apri score) for the noninvasive assessment of liver fibrosis in chronic hepatitis, which was published in hepatitis monthly (1). the authors valuated patients diagnosed with chronic hepatitis c and b and nonalcoholic fatty liver disease (nafld) and assessed their apri scores to predict the presence of fibrosis (metavir score of at least f1).